Fodexil1000 mg

Fodexil is a first-generation cephalosporin antibiotic used to treat infections caused by susceptible bacteria. Its established, guideline-supported uses include:

• Pharyngitis and tonsillitis caused by Group A beta-hemolytic streptococci (as an alternative to penicillin in appropriate patients, given for a full course to help prevent complications such as rheumatic fever).
• Urinary tract infections, including cystitis and pyelonephritis, caused by susceptible organisms such as Escherichia coli, Proteus mirabilis, and Klebsiella species.
• Skin and skin-structure infections, including abscesses, impetigo, and cellulitis, caused by susceptible Staphylococcus aureus and Streptococcus pyogenes.
• Uncomplicated respiratory tract infections (e.g. mild community-acquired bronchitis/bronchopneumonia) caused by susceptible organisms, in regions and guidelines where oral cephalosporins are used for this indication.

Fodexil is not recommended for infections of the central nervous system (e.g. meningitis) because of poor penetration into cerebrospinal fluid. As with all antibiotics, Fodexil should be prescribed only for infections proven or strongly suspected to be caused by susceptible bacteria, based on clinical judgment and, where possible, culture and susceptibility data.

Each dosage unit of Cefadroxil Monohydrate contains Cefadroxil Monohydrate as the active pharmaceutical ingredient, equivalent to a specified amount of cefadroxil base. Cefadroxil Monohydrate is available in Bangladesh in various strengths and formulations, including capsules and tablets (commonly 250 mg, 500 mg, and 1000 mg) and powder for oral suspension (commonly 125 mg/5 mL and 250 mg/5 mL after reconstitution), along with inactive excipients appropriate to each formulation.

Fodexil is a semi-synthetic, first-generation cephalosporin antibiotic for oral administration. It is the monohydrate salt form of cefadroxil, chemically related to cephalexin, and is used to treat a range of bacterial infections caused by susceptible gram-positive and gram-negative organisms.

Fodexil is well absorbed after oral administration and achieves therapeutic tissue and serum concentrations that are largely unaffected by food, which allows flexible dosing with or without meals.

Fodexil belongs to the first-generation cephalosporin class of beta-lactam antibiotics, structurally and mechanistically related to penicillins.

Cefadroxil Monohydrate is bactericidal. Like other beta-lactam antibiotics, it exerts its effect by binding to penicillin-binding proteins (PBPs) located on the bacterial cell wall, which inhibits the final transpeptidation (cross-linking) step of bacterial cell wall (peptidoglycan) synthesis. This weakens the cell wall, leading to cell lysis and death of susceptible bacteria.

Cefadroxil Monohydrate is active against many gram-positive organisms (e.g. Streptococcus pyogenes, methicillin-susceptible Staphylococcus aureus) and some gram-negative organisms (e.g. E. coli, Proteus mirabilis, Klebsiella pneumoniae). It is not active against methicillin-resistant staphylococci, enterococci, or most strains of Pseudomonas aeruginosa.

Pharmacokinetics: Cefadroxil Monohydrate is well absorbed orally, with peak serum concentrations reached in about 1.5–2 hours; absorption is not significantly affected by food. It is widely distributed in body tissues and fluids (but crosses poorly into cerebrospinal fluid), is minimally metabolized, and is eliminated largely unchanged by the kidneys via glomerular filtration and tubular secretion, with an elimination half-life of approximately 1.5 hours in patients with normal renal function.

Fodexil capsules, tablets, or reconstituted oral suspension should be taken by mouth. It may be taken with or without food; taking it with food or milk may help reduce stomach upset. Oral suspension should be shaken well before each dose and measured using an accurate dosing device. Doses should be spaced evenly as directed by the physician to maintain effective drug levels.

Fodexil has the following well-established clinically significant interactions:

• Probenecid: Competitively inhibits renal tubular secretion of Fodexil, resulting in higher and more prolonged serum concentrations. This combination may be used intentionally under medical supervision but requires awareness of increased drug exposure.
• Cholestyramine: Binds to cephalosporins in the gut and can reduce absorption of Fodexil; if co-administration is necessary, doses should be separated by several hours.
• Bacteriostatic antibiotics (e.g. tetracyclines, chloramphenicol, erythromycin): Concurrent use may theoretically antagonize the bactericidal action of Fodexil; concurrent use should generally be avoided unless directed by a physician.
• Oral anticoagulants (e.g. warfarin): Cephalosporins may enhance anticoagulant effect in some patients; closer monitoring of coagulation parameters is advisable if co-administered.

Always inform your physician or pharmacist about all medications, supplements, and herbal products you are taking before starting Fodexil.

Most patients tolerate Fodexil well. Reported side effects include:

• Common: Nausea, vomiting, diarrhea, abdominal discomfort, dyspepsia, and skin rash.
• Less common: Urticaria (hives), pruritus (itching), headache, dizziness, and vaginal itching/candidiasis.
• Rare but serious: Clostridioides difficile-associated diarrhea and pseudomembranous colitis (which can range from mild to life-threatening and may occur even weeks after stopping treatment), severe hypersensitivity reactions including anaphylaxis and angioedema, Stevens-Johnson syndrome, toxic epidermal necrolysis, reversible interstitial nephritis, transient elevations in liver enzymes, and blood disorders such as eosinophilia, leukopenia, neutropenia, or hemolytic anemia.

Seek prompt medical attention for severe or persistent diarrhea, signs of allergic reaction (rash, swelling, difficulty breathing), or any unusual or severe symptom while taking Fodexil.

Pregnancy: Animal reproduction studies with Fodexil have not shown evidence of impaired fertility or harm to the fetus; however, adequate and well-controlled studies in pregnant women are lacking. Fodexil should be used during pregnancy only if clearly needed and if the potential benefit justifies the potential risk to the fetus. Consult a physician before use during pregnancy.

Lactation: Fodexil is excreted in low concentrations in human breast milk. Caution is advised when administering to a nursing mother, as it could theoretically affect the infant's gut flora or cause sensitization. Use only if clearly needed and under medical supervision, and consult a physician promptly if the infant develops diarrhea, rash, or oral thrush.

Antibiotic stewardship: Take Fodexil exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice. Completing the full prescribed course helps prevent relapse and the development of antibiotic-resistant bacteria.

Penicillin allergy / cross-reactivity: Patients with a history of penicillin allergy may have a small but real risk of cross-reactivity to cephalosporins, including Fodexil. Use with caution, and avoid in patients with a history of severe or immediate-type penicillin hypersensitivity reactions (e.g. anaphylaxis).

Clostridioides difficile-associated diarrhea (CDAD): Fodexil, like nearly all antibacterial agents, has been associated with CDAD, ranging from mild diarrhea to fatal colitis. Evaluate if diarrhea occurs during or after treatment.

Renal impairment: Dose and/or dosing interval adjustment is required in patients with reduced renal function (see Dosage and Administration); renal function should be monitored in long-term therapy or in patients with pre-existing renal disease.

Superinfection: Prolonged use may result in overgrowth of non-susceptible organisms, including fungi; monitor for signs of superinfection.

Use with caution in patients with a history of gastrointestinal disease (e.g. colitis).

Overdose of Fodexil may cause nausea, vomiting, epigastric distress, diarrhea, and, in severe cases, neuromuscular hypersensitivity or seizures, particularly in patients with renal impairment. There is no specific antidote. In case of suspected overdose, seek immediate medical attention or contact a poison control center. Treatment is supportive and symptomatic; hemodialysis may help remove the drug in cases of severe renal impairment, but this should only be performed under medical supervision in a hospital setting.

Store at room temperature (below 30°C), away from light and moisture. If using reconstituted oral suspension, keep the container tightly closed, store in a refrigerator, and discard any unused portion after 14 days. Keep out of reach of children.

Renal impairment: Dose and interval adjustment required based on creatinine clearance (see Dosage and Administration); use with caution and monitor renal function.

Hepatic impairment: No specific dose adjustment is established; Fodexil is primarily renally eliminated, but use with caution and monitor liver function in patients with significant hepatic disease.

Elderly: Generally well tolerated; dose selection should account for age-related decline in renal function, and renal function should be assessed before and during therapy.

Pediatric patients: Safety and effectiveness have been established for the indications and age/weight-based dosing described above; use in neonates and very young infants should be guided by a pediatrician, as safety and dosing in this group are less well established.

Duration of Fodexil therapy depends on the infection being treated: a minimum of 10 days is required for streptococcal pharyngitis/tonsillitis to reduce the risk of rheumatic fever, while other infections (urinary tract, skin/soft tissue) are typically treated for 5–14 days as directed by the physician. The full prescribed course should always be completed, even if symptoms resolve earlier.

For Fodexil powder for oral suspension: tap the bottle to loosen the powder, then add the specified amount of water in two portions, shaking well after each addition, to reach the final volume marked on the label (the exact water volume depends on bottle size and is printed on the label/insert). Shake well before each use. After reconstitution, store in a refrigerator, keep the container tightly closed, and discard any unused suspension after 14 days.

Cefadroxil Monohydrate is classified as a first-generation cephalosporin antibiotic, part of the broader beta-lactam class of antimicrobial agents.

Cefadroxil Monohydrate exerts a bactericidal effect by binding to penicillin-binding proteins (PBPs) in the bacterial cell wall, thereby inhibiting the transpeptidation step of peptidoglycan (cell wall) synthesis. This disrupts cell wall integrity, causing bacterial cell lysis and death.

B (FDA legacy pregnancy category)

Fodexil is approved for use in pediatric patients for susceptible infections, including streptococcal pharyngitis/tonsillitis, urinary tract infections, and skin/soft-tissue infections, using weight-based dosing (typically 30 mg/kg/day in one or two divided doses, depending on indication). Safety and effectiveness in neonates and very young infants have not been well established, and use in this age group should be under close pediatric supervision. Oral suspension formulations are often preferred for children unable to swallow capsules or tablets, and doses should be measured accurately using a calibrated dosing device.